Condition
Decompensated Liver Cirrhosis clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Decompensated Liver Cirrhosis clinical trials that are recruiting, at sites in 9 countries (most in Germany (3), Belgium (2), France (2)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 9Countries
Newest Decompensated Liver Cirrhosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Single vs repeated cycles of G-CSF and darbepoetin in early decompensated cirrhosis | — | New Delhi, National Capital Territory of Delhi | Recruiting | Jun 4, 2025 |
| Atorvastatin plus beta-blockers for people with decompensated cirrhosis | Phase 2 | Charleston, West Virginia | Recruiting | Jan 9, 2025 |
| LEOPARD: Predicting liver transplant dropout with AI in European patients | — | Ghent, Belgium and 7 other locations | Recruiting | Dec 9, 2024 |
| Collecting data to improve liver transplantation predictions | — | Vienna and 52 other locations | Recruiting | Nov 5, 2024 |
| TIPS treatment for decompensated liver cirrhosis | — | Hanover, Lower Saxony | Recruiting | Mar 17, 2021 |
All recruiting trials (5)
-
Single vs repeated cycles of G-CSF and darbepoetin in early decompensated cirrhosis
This trial tests whether giving multiple rounds of G-CSF plus darbepoetin helps people with early decompensated cirrhosis more than a single round or standard care.
-
Atorvastatin plus beta-blockers for people with decompensated cirrhosis
This pilot Phase 2 trial will test whether adding atorvastatin 20 mg to standard non‑selective beta‑blocker therapy helps adults with decompensated cirrhosis avoid complications over 12 months.
-
LEOPARD: Predicting liver transplant dropout with AI in European patients
This project tests new AI-based models to predict which liver transplant candidates are at highest risk of dropout or death while on the waitlist.
-
Collecting data to improve liver transplantation predictions
This study is trying to use AI to better predict which liver transplant candidates are at risk of dropping out of the waitlist, so that more people can get fair access to transplants across Europe.
-
TIPS treatment for decompensated liver cirrhosis
Collecting clinical data and blood samples from adults with decompensated liver cirrhosis who receive a TIPS to try to improve how doctors choose who should get the procedure.
Related topics
Quick answers
How many Decompensated Liver Cirrhosis clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in Germany (3 trials), Belgium (2 trials), France (2 trials), Italy (2 trials), Netherlands (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.